Cannabinoids and psychotic symptoms: A potential role for a genetic variant in the P2X purinoceptor 7 (P2RX7) gene
- 1 August 2020
- journal article
- research article
- Published by Elsevier BV in Brain, Behavior, and Immunity
- Vol. 88, 573-581
- https://doi.org/10.1016/j.bbi.2020.04.051
Abstract
No abstract availableThis publication has 64 references indexed in Scilit:
- Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivityNature Medicine, 2012
- A novel approach of homozygous haplotype sharing identifies candidate genes in autism spectrum disorderHuman Genetics, 2011
- Genome-wide association study identifies five new schizophrenia lociNature Genetics, 2011
- Genome-wide meta-analyses identify multiple loci associated with smoking behaviorNature Genetics, 2010
- Identification and characterization of a novel variant of the human P2X7 receptor resulting in gain of functionPurinergic Signalling, 2009
- Genetics of the P2X7 receptor and human diseasePurinergic Signalling, 2009
- P2X7 receptor and macrophage functionPurinergic Signalling, 2009
- A Unified Approach to Genotype Imputation and Haplotype-Phase Inference for Large Data Sets of Trios and Unrelated IndividualsAmerican Journal of Human Genetics, 2009
- Emerging role of the cannabinoid receptor CB2in immune regulation: therapeutic prospects for neuroinflammationExpert Reviews in Molecular Medicine, 2009
- The International HapMap ProjectNature, 2003